BMJ Best Practice

参考文献

关键文献

Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. May 2008 [internet publication].

Australian Institute of Health and Welfare 2001 National Drug Strategy Household Survey: Detailed Findings. Drug Statistics Series No. 11. 2002. AIHW Cat. No. PHE-41.

National Institute for Health and Care Excellence. Stop smoking interventions and services. March 2018 [internet publication].

Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012 Jun;107(6):1066-73.

New Zealand Guidelines Group. The New Zealand guidelines for helping people to stop smoking. June 2014 [internet publication].

Le Foll B, Melihan-Cheinin P, Rostoker G, et al; Working Group of AFSSAPS. Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur Psychiatry. 2005 Aug;20(5-6):431-41.

Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 Dec 5;72(25):3332-3365.

Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;(5):CD000146.

Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009 Feb;18(1):34-42.

Coleman T, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;(12):CD010078.

Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009 Jun;18(11):1533-40.

参考文章

1.  Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45.

2.  Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. May 2008 [internet publication].

3.  Maciosek M, Coffield A, Edwards N, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31:52-61.

4.  Peto R, Lopez AD. The future worldwide health effects of current smoking patterns. In: Koop CE, Pearson CE, Schwarz MR, eds. Critical issues in global health. New York, NY: Jossey-Bass; 2001.

5.  Office for National Statistics (UK). Statistical bulletin - adult smoking habits in the UK: 2017. July 2018 [internet publication].

6.  Australian Institute of Health and Welfare 2001 National Drug Strategy Household Survey: Detailed Findings. Drug Statistics Series No. 11. 2002. AIHW Cat. No. PHE-41.

7.  Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-9.

8.  US Department of Health and Human Services. The health consequences of smoking - 50 years of progress. A report of the Surgeon General. January 2014 [internet publication].

9.  Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018 Jan 24;360:j5855.

10.  Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004 Jun 26;328(7455):1519.

11.  Messer K, Pierce J, Zhu S-H, et al. The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation. Tob Control. 2007 Apr;16(2):85-90.

12.  Drake P, Driscoll AK, Mathews TJ. Cigarette smoking during pregnancy: United States, 2016. NCHS Data Brief. 2018 Feb;(305):1-8.

13.  Niaura R Shadel WG, Morrow K, et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808-812.

14.  Farrelly MC, Pechacek TF, Thomas KY, et al. The impact of tobacco control programs on adult prevalence. Am J Public Health. 2008;98:304-309.

15.  Hopkins DP, Briss PA, Ricard CJ, et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001;20(suppl 2):16-66.

16.  Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5):CD000165.

17.  National Institute for Health and Care Excellence. Stop smoking interventions and services. March 2018 [internet publication].

18.  Swartz S, Hays J. Office-based intervention for tobacco dependence. Med Clin North Am. 2004 Nov;88(6):1623-41;xii-iii.

19.  Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119-27.

20.  Aveyard P, Massey L, Parsons A, et al. The effect of Transtheoretical Model based interventions on smoking cessation. Soc Sci Med. 2009 Feb;68(3):397-403.

21.  Hughes J, Goldstein M, Hurt R, et al. Recent advances in the pharmacotherapy of smoking. JAMA. 1999;281:72-76.

22.  Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;(2):CD007253.

23.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

24.  Rigotti NA, Thorndike AN. Reducing the health burden of tobacco use: What is the doctor's role? Mayo Clin Proc. 2001;76:121-123.

25.  Aveyard P, West R. Managing smoking cessation. BMJ. 2007;335:37-41.

26.  Linder JA, Rigotti NA, Schneider LI, et al. An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med. 2009;169:781-787.

27.  Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012 Jun;107(6):1066-73.

28.  Borland R, Balmford J, Bishop N, et al. In-practice management versus quitline referral for enhancing smoking cessation in general practice: a cluster randomized trial. Fam Pract. 2008 Oct;25(5):382-9.

29.  American Academy of Family Physicians. Ask and act: a tobacco cessation program. 2010 [internet publication].

30.  Bize R, Burnand B, Mueller Y, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2012;(12):CD004705.

31.  McClure JB, Ludman EJ, Grothaus L, et al. Impact of a brief motivational smoking cessation intervention the Get PHIT randomized controlled trial. Am J Prev Med. 2009 Aug;37(2):116-23.

32.  New Zealand Guidelines Group. The New Zealand guidelines for helping people to stop smoking. June 2014 [internet publication].

33.  Le Foll B, Melihan-Cheinin P, Rostoker G, et al; Working Group of AFSSAPS. Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur Psychiatry. 2005 Aug;20(5-6):431-41.

34.  Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 Dec 5;72(25):3332-3365.

35.  Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007.

36.  Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001292.

37.  Oncken CA, Kranzler HR. What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? Nicotine Tob Res. 2009 Nov;11(11):1265-73.

38.  Fanshawe TR, Halliwell W, Lindson N, et al. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017 Nov 17;(11):CD003289.

39.  Kendzor DE, Businelle MS, Poonawalla IB, et al. Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment. Am J Public Health. 2015 Jun;105(6):1198-205.

40.  Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;(5):CD004307.

41.  Halpern SD, French B, Small DS, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015 May 28;372(22):2108-17.

42.  Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;(5):CD000146.

43.  Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009 Nov;66(11):1253-62.

44.  US Food and Drug Administration. Vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS). September 2018 [internet publication].

45.  National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems; Eaton DL, Kwan LY, Stratton K. Public health consequences of e-cigarettes. Washington, DC: National Academies Press; 2018.

46.  Cobb NK, Byron MJ, Abrams DB, et al. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health. 2010 Dec;100(12):2340-2.

47.  Public Health England (UK). Evidence review of e-cigarettes and heated tobacco products 2018: executive summary. March 2018 [internet publication].

48.  Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;(5):CD006103.

49.  Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009 Feb;18(1):34-42.

50.  Shiffman S, Ferguson SG. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction. 2008 Apr;103(4):557-63.

51.  Shiffman S, Ferguson SG, Strahs KR. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med. 2009 Feb;36(2):96-104;e1.

52.  Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009 Apr 2;338:b1024.

53.  Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):687-94.

54.  Coleman T, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;(12):CD010078.

55.  Chamberlain C, O'Mara-Eves A, Porter J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017;(2):CD001055.

56.  Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med. 2008 Oct 13;168(18):1950-60.

57.  Paciullo CA, Short MR, Steinke DT, et al. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery. Ann Pharmacother. 2009 Jul;43(7):1197-202.

58.  Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med. 2007 Jun;35(6):1517-21.

59.  Bernstein SL, D'Onofrio G, Rosner J, et al. Successful tobacco dependence treatment in low-income emergency department patients: a randomized trial. Ann Emerg Med. 2015 Aug;66(2):140-7.

60.  Hughes J. Depression during tobacco abstinence. Nicotine Tob Res. 2007 Apr;9(4):443-6.

61.  Thomas RE, Baker PR, Thomas BC, et al. Family-based programmes for preventing smoking by children and adolescents. Cochrane Database Syst Rev. 2015;(2):CD004493.

62.  Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2015;(10):CD004306.

63.  Boyle RG, Enstad C, Asche SE, et al. A randomized controlled trial of telephone counseling with smokeless tobacco users: the ChewFree Minnesota study. Nicotine Tob Res. 2008 Sep;10(9):1433-40.

64.  Ellerbeck EF, Mahnken JD, Cupertino AP, et al. Effect of varying levels of disease management on smoking cessation: a randomized trial. Ann Intern Med. 2009 Apr 7;150(7):437-46.

65.  Myung SK, McDonnell DD, Kazinets G, et al. Effects of web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med. 2009 May 25;169(10):929-37. [Erratum in: Arch Intern Med. 2009 Jul 13;169(13):1194.]

66.  Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015 Sep 22-29;314(12):1255-63.

67.  Colby SM, Gwaltney CJ. Pharmacotherapy for adolescent smoking cessation. JAMA. 2007 Nov 14;298(18):2182-4.

68.  Hughes JR, Stead LF, Hartmann-Boyce J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014;(1):CD000031.

69.  US Food and Drug Administration (FDA). FDA notice: varenicline (marketed as Chantix) and bupropion (marketed as Zyban, Wellbutrin, and generics) - Black Box warning. July 2009 [internet publication].

70.  Kortmann GL, Dobler CJ, Bizarro L, et al. Pharmacogenetics of smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):17-28.

71.  Rose JE, Behm FM, Drgon T, et al. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med. 2010 Jul-Aug;16(7-8):247-53. [Erratum in: Mol Med. 2012;18(1):729.]

72.  Cornuz J, Zwahlen S, Jungi WF, et al. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One. 2008;3:e2547.

73.  Hartmann-Boyce J, Cahill K, Hatsukami D, et al. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012;(8):CD007072.

74.  Cahill K, Ussher M. Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database Syst Rev. 2011;(3):CD005353.

75.  University of Minnesota Transdisciplinary Tobacco Use Research Center (UMN TTURC). Hope or hazard? What research tells us about "potentially reduced-exposure" tobacco products. April 2005 [internet publication].

76.  Stratton KS, Wallace R, Bondurant S, eds. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press; 2001.

77.  Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007 Jun;9(6):631-46.

78.  Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009 Apr;15(3):231-40.

79.  Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009 Feb;36(2):165-73.

80.  Vidrine DJ, Arduino RC, Lazev AB, et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006 Jan 9;20(2):253-60.

81.  Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction. 2009 Nov;104(11):1792-804.

82.  Taylor GMJ, Dalili MN, Semwal M, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017;(4):CD007078.

83.  Whittaker R, McRobbie H, Bullen C, et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016;(4):CD006611.

84.  Tahiri M, Mottillo S, Joseph L, et al. Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med. 2012 Jun;125(6):576-84.

85.  Maziak W, Jawad M, Jawad S, et al. Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev. 2015;(7):CD005549.

86.  Hughes J, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004 Jan;99(1):29-38.

87.  Hajek P, Stead LF, West R, et al. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2013;(8):CD003999.

88.  Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med. 2010 Feb 2;152(3):144-51.

89.  Cooney JL, Cooney NL, Pilkey DT, et al. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction. 2003 Jul;98(7):913-21.

90.  Colby SM, Rohsenow DJ, Monti PM, et al. Effects of tobacco deprivation on alcohol cue reactivity and drinking among young adults. Addict Behav. 2004 Jul;29(5):879-92.

91.  Aubin HJ, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012 Jul 10;345:e4439.

92.  Kim K, Park SM, Lee K. Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men. Eur Heart J. 2018 May 1;39(17):1523-31.

93.  Farley AC, Hajek P, Lycett D, et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2012;(1):CD006219.

94.  Yang M, Bhowmik D, Wang X, et al. Does combination pharmacological intervention for smoking cessation prevent post-cessation weight gain? A systemic review. Addict Behav. 2013 Mar;38(3):1865-75.

95.  Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009 Jun;18(11):1533-40.

96.  van den Brand FA, Nagelhout GE, Reda AA, et al. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2017;(9):CD004305.

97.  Mills AL, Messer K, Gilpin EA, et al. The effect of smoke-free homes on adult smoking behavior: a review. Nicotine Tob Res. 2009 Oct;11(10):1131-41.

98.  Guilamo-Ramos V, Jaccard J, Dittus P, et al. The Linking Lives health education program: a randomized clinical trial of a parent-based tobacco use prevention program for African American and Latino youths. Am J Public Health. 2010 Sep;100(9):1641-7.

使用此内容应接受我们的免责声明。